Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Pathology and AI: Page 4
Ginkgo Bioworks, Google Cloud to collaborate on AI tools
By
Matt Limb
Ginkgo Bioworks and Google Cloud have entered into a strategic five-year strategic partnership to develop artificial intelligence (AI) tools for biology and biosecurity.
September 6, 2023
Lunit to present results of AI-based immunotherapy predictive test study at WCLC 2023
By
LabPulse.com staff writers
Lunit announced the presentation of data from a collaborative study on the use of the Lunit SCOPE IO test to predict immunotherapy treatment outcomes in lung cancer at the 2023 World Conference on Lung Cancer (WCLC 2023).
August 28, 2023
AI neuroimaging model aims to predict neuropathic pain treatment responses
By
Matt Limb
A magnetic resonance (MR) neuroimaging model which uses artificial intelligence (AI) to identify new biomarkers could lead to more effective medical treatment for chronic nerve pain, say the researchers developing the model.
August 25, 2023
Gene-specific approach recommended for variant pathogenicity prediction
By
Matt Limb
A research team investigated the efficacy of gene-specific supervised machine learning in predicting the pathogenicity of rare BRCA1/2 missense variants compared to the disease-specific approach.
August 22, 2023
AI system in development aims for earlier endometriosis diagnosis
By
Matt Limb
IMAGENDO uses machine learning to digitally combine the diagnostic capabilities of pelvic scans and MRI to identify endometriosis lesions. The researchers are seeking to optimize and validate the algorithm.
August 21, 2023
BARDA commits $30.5M to the development of musculoskeletal imaging system
By
Nick Paul Taylor
BARDA has committed funding to support the development of a device that could quickly triage fracture severity in the wake of a chemical, biological, radiological, or nuclear attack and thereby preserve x-ray resources for the highest-priority patients.
August 11, 2023
AI model traces cancers of unknown primary origin to their sources
By
LabPulse.com staff writers
In results from a study published recently in Nature, OncoNPC was able to accurately predict the origin of about 80% of the tumors tested, including metastatic disease.
August 8, 2023
Dr. Atul Butte calls for ānew system of precision medicineā in plenary lecture at AACC 2023
By
Nick Paul Taylor
The computer scientist told attendees how data-driven initiatives have transformed medical practice at the University of California health system, and how the combination of EHRs and AI could identify ways to cut the costs of treating patients.
July 31, 2023
Molecular pathology bodies recommend expansion of pharmacogenomic test panels
By
Nick Paul Taylor
In its latest project, the working group investigated clinical CYP3A4 and CYP3A5 PGx testing, leading the AMP and its collaborators to issue consensus recommendations on the genes.
July 18, 2023
DiamiR Biosciences partners with JADBio on diagnostic tests, validation for biomarker panels
By
Matt Limb
Under the deal, DiamiR will apply the capabilities of JADBioās Automated Machine Learning (AutoML) bioinformatics platform and services to its own microRNA platform.
July 12, 2023
New scanning method creates whole-body āatlasesā of biological systems
By
Matt Limb
wildDISCO can create whole-body āatlasesā focusing on the nervous system, lymphatic vessels, blood vessels, and immune cells to highlight normal structures and tumors in early stages of formation.
July 13, 2023
CellChorus awarded two grants to accelerate single-cell analysis platform
By
LabPulse.com staff writers
The grants will be used to accelerate the development of CellChorusā Time-lapse Imaging Microscopy in Nanowell Grids (TIMING) platform for single-cell analysis.
June 30, 2023
Previous Page
Page 4 of 176
Next Page
